Recombinant NG2 anticorps

N° du produit ABIN7490778

Cet anticorps anti-NG2 Chimeric Human (Clone DMC466) (ABIN7490778) détecte spécifiquement NG2 dans FACS. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant NG2 anticorps (ABIN7490778)

Antigène: NG2 (MCSP) (Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))

Type d'anticorp: Recombinant Antibody

Fragment: Fc fragment

Reactivité: Humain

Hôte: Human, Lapin

Clonalité: Chimeric

Conjugué: Cet anticorp NG2 est non-conjugé

Application: Flow Cytometry (FACS)

Clone: DMC466

Détail du produit anti-NG2 anticorps

Fonction: Anti-CSPG4 antibody(DMC466), IgG1 Chimeric mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Information d'application

Indications d'application: Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur NG2

Antigène: NG2 (MCSP) (Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))

Autre désignation: CSPG4

Sujet: CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2,
Description: ,A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008]

UniProt: Q6UVK1

Pathways: Glycosaminoglycan Metabolic Process